Top news

View all

25 January 2023

COVID-19 Vaccine Delivery Partnership boosts Sierra Leone COVID-19 Vaccination with US$ 2.8 million worth donation

COVID-19 Vaccine Delivery Partnership, (CoVDP) has handed over vehicles, motorbikes and computers worth of US$ 2.8M to support Sierra Leone Vaccination efforts.

19 January 2023

The US$ 500 million challenge: Gavi launches INFUSE 2.0 to scale up innovations in immunisation

INFUSE is an innovation scaling hub that matches investors with innovators and entrepreneurs to help scale up new ways to improve vaccination coverage in lower-income countries

19 January 2023

Gavi, Unilever Lifebuoy and The Power of Nutrition join forces in tripartite immunisation, handwashing and nutrition programme to tackle preventable diseases

Gavi’s first multisectoral private sector partnership to include nutrition as part of holistic approach to disease prevention.

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support. Published every two weeks.

View all

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

 

 

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

27 January 2023

Africa’s Climate Crisis Is a Health Crisis

Africans are facing increased but underappreciated risks to their health as a result of rising temperatures and changing climatic conditions. And since many of these new threats cannot simply be managed with "climate adaptation," policymakers…

27 January 2023

Book Review: Behind Wall Street’s Huge Gamble on Cancer Drugs

Nathan Vardi’s “For Blood and Money” shows how stock traders funded the race to develop two rival blood cancer drugs.

27 January 2023

Vaccine hesitancy in South Africa: COVID experience highlights conspiracies, mistrust and the role of the media

Curbing vaccine hesitancy is as much a matter of acknowledging its social, historical, and cultural roots as it is of addressing its clinical dimensions.

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Our impact

Syringe >981 million children immunised
First aid locator >16.2 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >185.3 US$ billion in economic benefits for countries (2000–2021)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter